Muthu Boy Alert: Hims & Hers Health (HIMS) Jumps 37% After Hours — 39% Short Interest Could Spark $100 Short Squeeze 🚀
Congrats to all the Hims & Hers Health (HIMS) holders — the stock just jumped 40% after hours! 🚀
Looks like Novo Nordisk (Novo Nordisk (NVO)) may have dropped the lawsuit and decided to partner with HIMS, selling Novo-branded GLP-1 receptor agonists.
Even more interesting… HIMS is about 39% shorted. 👀
That means if the news is real and momentum continues, short sellers may have to rush to cover.
Muthu Boy can already smell the possibility of a short squeeze cooking in the pan… 🍳
Some traders are even whispering that if a squeeze happens, the stock could go parabolic toward $100. 📈🔥
Meanwhile, Muthu has her own dream:
If everyone takes GLP-1 and doesn’t get fat… maybe they can eat more prata without guilt.
Please support Prata Boy’s shop.
More GLP-1, more prata. Everybody wins. 🫓😄
@Tiger_comments @Daily_Discussion @TigerStars @TigerObserver @TigerPM @Tiger_comments
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
